About this trial
1. To assess the frequency, clinical presentation, microbiological and radiological characteristics of liver abscesses. 2. To evaluate the management plan and treatment outcome of liver abscess. 3. To study risk factors of liver abscess.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of LA will be based on typical appearance on ultrasound (US) or computed tomography (CT) of abdomen with clinical features consistent with the diagnosis (fever, chills, jaundice, right upper quadrant pain/epigastric discomfort).
US or CT-guided aspiration of pus from a hepatic lesion.
Complete resolution of radiological abnormalities following antimicrobial therapy.
Disqualifiers
Liver abscess that occurs secondary to hydatid cyst.
Liver abscess associated with underlying malignancy.
Patient with incomplete medical records.
Trial population
All patients diagnosed with liver abscess according to inclusion and exclusion criteria.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
1. To assess the frequency, clinical picture, microbiological and radiological characteristics of liver abscesses.
Data will be statistically evaluated by SPSS version 22. Numerical data will be expressed as means ± SDs. Categorical data will be expressed as frequencies (percentages). Comparison between groups will be conducted using t-test or Chi square test as appropriate. P value \<0.05 will be considered as significant.
Secondary outcomes
2. To evaluate the management plan and treatment outcome of liver abscess.
Data will be statistically evaluated by SPSS version 22. Numerical data will be expressed as means ± SDs. Categorical data will be expressed as frequencies (percentages). Comparison between groups will be conducted using t-test or Chi square test as appropriate. P value \<0.05 will be considered as significant.
3. To study risk factors of liver abscess.
Data will be statistically evaluated by SPSS version 22. Numerical data will be expressed as means ± SDs. Categorical data will be expressed as frequencies (percentages). Comparison between groups will be conducted using t-test or Chi square test as appropriate. P value \<0.05 will be considered as significant.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: